/DXCM

Dexcom Inc

DXCM

$83.03USD↓-1.75%-1.48 today

MARKET CAP

31.3B

P/E (TTM)

34.8x

FWD P/E

29.4x

DAY RANGE

$83 – $86

52W RANGE

$54

$93

AI Summary

Stalk

StalkMedium

DXCM is in a Stage 2 corrective phase within an overall uptrend, pulling back into the rising 50-period SMA. Medium-term bias remains bullish as long as the 50 SMA holds. Short-term price is below the 9- and 20-period EMAs, signaling a pause rather than a reversal. Execution should be deferred until a clear bounce or reversal candle off the 50 SMA confirms support. A breakdown below this zone risks a deeper retracement toward the 200-period SMA.

↑Q2 2026 revenue $1.31 B (+13% YoY) driven by global CGM demand
↑Anticipated Medicare coverage for ~12 M type 2 patients expands addressable market
↓Negative earnings yield suggests stock may be overvalued amid competitive pressure

Full analysis →

Buying

10

institutions

Selling

9

institutions

New Positions

1

this quarter

Filing Period

Q1 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	SELL	38.24 M	2.58 B	+-720.23 K	+5.3%	0.04%
JH Janus Henderson Group Plc Q1 2026	BUY	5.29 M	332.15 M	+3.29 M	+150.3%	0.08%
JC Jpmorgan Chase & Co Q2 2026	SELL	3.33 M	232.69 M	+-2.67 M	-37.3%	0.01%
AC Aqr Capital Management LLC Q2 2026	BUY	3.24 M	218.06 M	+1.06 M	+59.8%	0.08%
CA Citadel Advisors LLC Q2 2026	BUY	2.76 M	185.92 M	+73.69 K	+10.2%	0.02%
RT Renaissance Technologies LLC Q2 2026	BUY	1.63 M	109.83 M	+47.80 K	+10.5%	0.15%
CP California Public Employees Retirement System Q2 2026	BUY	638.29 K	42.99 M	+947.00	+7.4%	0.02%
WP Woodline Partners LP Q2 2026	SELL	536.70 K	36.15 M	+-489.94 K	-43.9%	0.11%
MM Millennium Management LLC Q2 2026	SELL	471.59 K	31.76 M	+-1.30 M	-71.5%	0.01%
BA Bridgewater Associates, LP Q2 2026	BUY	400.93 K	27.00 M	+261.24 K	+207.8%	0.11%
MG Man Group Plc Q2 2026	BUY	394.45 K	26.57 M	+36.61 K	+18.2%	0.04%
PA Point72 Asset Management, L.P. Q2 2026	SELL	290.54 K	19.57 M	+-45.36 K	-7.2%	0.02%
FA Fisher Asset Management, LLC Q2 2026	SELL	61.11 K	4.12 M	+-127.54 K	-65.3%	0.00%
TR T. Rowe Price Investment Management, Inc. Q2 2026	BUY	35.42 K	2.39 M	+32.12 K	+1052.7%	0.00%
BH Brevan Howard Capital Management LP Q2 2026	SELL	32.81 K	2.21 M	+-16.43 K	-28.5%	0.02%
RC Rockefeller Capital Management L.P. Q2 2026	BUY	17.48 K	1.18 M	+2.42 K	+24.5%	0.00%
PA Polar Asset Management Partners Inc. Q2 2026	BUYNEW	3.21 K	216.13 K	+3.21 K	+0.0%	0.00%
BA Balyasny Asset Management L.P. Q2 2026	SELL	0.00	0.00	+-566.31 K	-100.0%	0.00%
HS Hussman Strategic Advisors, Inc. Q2 2026	SELL	0.00	0.00	+-10.50 K	-100.0%	0.00%